Objective-(1) To assess the personality profiles of the anabolic androgenic steroid users (AAS) and (2) to determine whether valid premorbid personality traits could be obtained from cross sectional assessment using multisource data. Methods-The first author became a participant-observer in a group of body builders. An experimental group of body builders who had been using AAS for no more than 18 months (n=12) was identified. A group of control subjects, each of whom claimed that he did not, and never had, used AAS (n=12) was also recruited during this period. Key informants played a crucial role in recruiting subjects representative of the AAS and body building communities. An interview schedule based on the Diagnostic and statistical manual of mental disorders (DSM3-R) personality disorder criteria was conducted with each subject. Additional data were obtained from an AAS using informant and significant others including family and friends. Results-The user group was significantly heavier than the control group and showed abnormal personality traits, in contrast to the control group. Personality traits of AAS users before the onset of AAS use, assessed retrospectively, were not different from personality traits of control subjects. There were significant differences between the before and after personality traits in AAS user group. Conclusions-The results suggest (1) that AAS use is associated with significant disturbances in personality profile, and (2) that these personality disturbances are possibly the direct result of AAS use. (BrJ Sports Med 1996;30:246-250) 
anabolic-androgenic steroids (AAS) was restricted mainly to highly trained athletes, particularly those involved in power activities such as weight lifting.' Since then the use of AAS has extended beyond the confines of competitive sport to include recreational and non-competitive athletes and school children,2" who now make up the large majority of AAS users.
Although the physical and physiological effects of AAS use have been studied exten- sively, the real psychological and behavioural effects associated with their use are less well understood. This state of affairs may in part result from the fact that (1) most information of the psychological effects of these agents is anecdotal, and (2) most recent studies are cross sectional, so that the personality profiles of the subjects before AAS use began are not known. In addition, the effects of large non-therapeutic doses and combinations of AAS can be studied only in free living populations, as ethical constraints prevent such studies being performed under medical supervision.
Nevertheless, concurrent with the more widespread abuse of AAS has come a series of studies linking their use with marked psychiatric effects including personality disorders. "6 Included among these disorders are the paranoid, schizotypal, antisocial, borderline, histrionic, narcissistic, and passive-aggressive personality trait disorders. These disorders are socially and personally debilitating and at times may profoundly affect the social functioning of the individual. Accordingly, this study was designed to determine the effects of AAS use on personality traits in a group of body builders ingesting high doses of AAS in multiple combinations (stacking). Data were obtained from an interview schedule based on the Diagnostics and statistical manual of mental disorders (DSM3-R) personality disorder criteria.7 After months of observation of the subjects' behaviour, the first author and knowledgeable informants such as friends were able to validate the subjects' assessment of their own personality traits. If discrepancies occurred between the assessments of a subject, criteria were scored on the basis of consensus reached by the above persons.
The first author (CJG) became a non-AAS using member of a subgroup of bodybuilders who used AAS. This study allowed the personality traits to be observed uniquely at first hand in subjects using high doses and multiple combinations of AAS. However, a potential weakness of the study was that the premorbid personality traits of the AAS users could not be assessed directly as they had already been using AAS chronically for varying periods. Thus premorbid personality traits were assessed from historical recall of subjects and were compared to data from a group of non-using bodybuilders drawn from the same socioeconomic population and matched for age.
Methods
In order to assess the effects of anabolic steroid use on personality traits and separate underly-ing psychiatric symptoms from those induced by AAS exposure, it was necessary for CJC to work closely with bodybuilders from five Cape Town gymnasia. This proximity was made possible by his becoming a participant observer, by taking part in all the activities of the group, and in so doing gaining their trust. The initial infiltration was made possible by his gaining the friendship of two key individuals in the group; their friendship led to his acceptance by most of the members of the group.
As CJC's acceptance into the group increased, he was able to identify an experimental group of bodybuilders who had been using AAS for no more than 18 months (n= 12). Recruitment of subjects for the study occurred over a five week period. Key informants played a crucial role with respect to recruitment of subjects representative of the AAS and body building communities. A group of control subjects, each of whom claimed that he did not, and never had, used AAS (n=12), was also recruited during this period.
As a result of the selection process, the 24 male subjects, aged between 17 and 26, were recruited from an estimated population of between 400 and 600 committed body builders. Equal numbers of subjects were available in each group (n= 12).
Through frequent discussions during the observational period, subjects were made aware of CJC's interest in drug related research, and of his interest in their personal lives and of the possible effects of AAS on their personalities. Subjects were fully informed several weeks before the interviews of the goal of the intended interviews. In particular there was complete transparency of the intentions of the authors. Support for the proposed study was given by all the subjects for varying personal reasons including the desire to know more about themselves and the wish to participate in furthering scientific knowledge in this field.
Each subject was interviewed once for data collection. The first 20 minutes of the interviews were unstructured and were used, if necessary, to relax the subjects and to assure them of the confidential nature of the study. Interviews took place where subjects felt most relaxed, but were conducted under schedules. The interview schedules were based on the Diagnostic and statistical manual of mental disorders (DSM3-R) criteria for personality trait disorders.7 For each of the 11 personality disorders, subjects were given a list of the criteria denoting that personality trait disorder, and asked to consider carefully which if any of the criteria they satisfied. There was complete response on all the criteria by all the subjects. Moreover, subjects were consistent in nominating or denying criteria that were common to several disorders. After five months of observation of the subjects' behaviour, CJC and knowledgeable informants such as friends were able to validate the subjects' assessment of their own personality traits. If discrepancies occurred between these assessments, criteria were scored on the basis of consensus reached by the above persons. Paired Student's t statistics were used to compare differences within the AAS user group, and the unpaired two sample Student's t statistic between the control group and the AAS users. The Kruskal-Wallis test was used to evaluate differences between the control group and estimated scores of the AAS users before and after AAS use as a precaution against any unrecognised small sample violations of t test assumptions. Differences were considered statistically significant for P less than 0.05.
Results
The mean (SD) age, height, and mass of the user group was 22.3(2.5) years; 1.83(0.52) m, and 103(13.4) kg respectively; and that of the controls was 20.9(2.3) years; 1.82(0.70) m, and 82.5(9.1) kg. Although the age and height of the two groups were similar, reported masses were greater in AAS users (P<0.05) .
All the experimental subjects used two or more AAS concurrently on at least one occasion during the study. This activity, called stacking, was a common occurrence, the subjects often using combinations of AAS depending on what was both available and affordable. As a result combinations and Table 1 Average dosages and numbers of users for the different anabolic steroids used by the 12 AAS using body builders in this study Table 2 lists the average scores and standard deviations for numbers of disorder criteria on 11 personality traits measuring eccentric, flamboyant, and anxious features of behaviour in the control and user groups. There were no statistically significant differences on these scales between the control and recall group scores (columns A and C). Four individuals (33%) within each of these two groups showed at least one threshold criterion somewhere among these scales, though the total number of thresholds attained was higher in the AAS recall scores," than in the control scores. 6 A twelfth variable did indicate a significant difference between control and recall scores, but was eliminated from further analysis on the basis that at least one such statistical artefact will arise by chance in a study of 12 variables with a probability of about 46%. On found that 85% of 20 AAS users showed personality disorders or abnormal personality traits on the personality disorder questionnaire (PDQ). Our results are similar (83%). Similarly, although the findings of Perry and Hughes'4 were not as clear and marked as in the aforementioned studies, they found that AAS users showed more personality disturbances overall than a control group of non-AAS users. Su et al5 also found a significant impact on personality even during short term, relatively low dose AAS use without stacking.
The issue of publication bias arises in such cases. Journal articles are generally required to show statistically significant results before being accepted for publication. Thus studies which might give contrasting evidence of an absence of effects never reach a wider readership. In this instance we have not been able to trace any such studies. Furthermore, we believe that the interpretation of AAS as a cause of behavioural change is reasonable and not an artefact of publication bias.
In general the interpretation of most studies of the purported effects of AAS use on personality has been hampered by the absence of information about premorbid personality traits in current AAS users. For example, an individual may satisfy the diagnostic number of criteria for a personality disorder before AAS exposure. AAS use may exacerbate the disorder. If no premorbid data are available, the disorder may be attributed to the effects of AAS abuse. This notion is corroborated by the finding that one in three users (33%) in this study satisfied the diagnostic number of criteria for at least one disorder before AAS exposure. In contrast, no such abnormalities were present in the control group. The possibility that personality disorders may predispose to AAS use should be considered.
Furthermore retrospective assessment of personality traits is problematic. The few studies which have attempted to control for premorbid personality traits had non-AASusing controls to determine an average premorbid proffle.4"1 However, because a drug effect is dependent on the interaction of various influences in a particular context, there can be a wide variation in the manner in which different individuals respond to the same drugs. In addition, because of varying influences affecting drug responses, psychological effects may vary between different socioeconomic settings, different AAS and dosages used, and between different AAS using communities. Hence, if these factors are not controlled, choosing of non-AAS-users as subjects to control for premorbid traits in the AAS using community may not be valid.
The controls in this study were carefully matched for socioeconomic background and age. There were no significant differences in personality disorders between the control and user group before AAS exposure. We suggest that cross sectional assessment using multisource data was successful in assessing the premorbid personalities of users, despite major methodological problems.
The importance of controlling for premorbid personality traits cannot be overemphasised because effective diagnosis, intervention, and treatment in a clinical setting may depend on knowing which disorders or symptoms are a natural part of the patient's personality and which are induced by substance abuse.
In conclusion, this study suggests (1) that AAS use significantly increases the frequency and severity of symptoms of personality disorders; and (2) The diagnosis of Achilles tendon rupture can be difficult even for experienced practitioners, and a significant number of patients can be initially misdiagnosed. When examined soon after the injury, a tear in the substance of the tendon can be seen and palpated. With increased time after the tear, the gap can be obliterated by oedema, and palpation becomes unreliable.
In addition to the tests described in this journal in the June issue (volume 30, page 124), two other clinical tests should be mentioned.
Matles test
The patient, lying prone and with feet over the end of the examination couch, is asked to flex the knee actively to 90°. The position of the ankle and feet is observed during this movement. If the foot on the affected side falls into neutral or into dorsiflexion, an Achilles tendon rupture is diagnosed. In normal patients, the foot remains in slight planter flexion when the knee is flexed to 90'.1
Needle test With the patient prone, a small gauge needle is inserted at a right angle through the skin of the calf, just medial to the midlline, 10 cm proximal to the superior border of the calcaneum. The needle should be inserted only until the tip is just within the substance of the tendon. The foot is then passively and alternately dorsiflexed and plantarflexed. Two responses may occur. The needle may swivel so that it points in the direction opposite to the motion of the ankle (that is, when the ankle is dorsiflexed, the needle points distally). This indicates that the tendon is intact in the portion distal to the needle insertion point. The other possible response is that the needle does not move, or moves slightly in the same direction of the motion of the ankle (that is, when the ankle is dorsiflexed, the needle points proximally). In this second instance, the Achilles tendon has lost its continuity between the needle and its insertion.2
More on the calf squeeze test Given the history of the test, the correct denomination should be Simmond's test. Simmonds described his test in a paper on the diagnosis ofAchilles tendon rupture, published five years before Thompson's papers.3 Thompson and Doherty published jointly an article in an American journal solely on this test in 1962.4 Practically the same paper was published by Thompson, without his colleague, some months later in a European journal. 5 In the British Isles, the calf squeeze test is called "Simmond's test", and in most of the rest of the world "Thompson's test", not acknowledging that Doherty was one of the original authors. To avoid offending the sensitivities of British or American influenced surgeons, it is better to describe the test as the "calf squeeze test" and cite the fact that Simmonds described it well before Thompson and Doherty. To avoid confusion on what constitutes a positive test, one should probably just mention whether the ankle plantar flexes on squeezing the calf muscles. If it does, the tendon is most likely intact (but beware of the plantaris!). 
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